Cardio-Oncology

P037 - CLINICAL CHARACTERISTICS, ECHOCARDIOGRAPHIC FEATURES, AND OUTCOMES OF PATIENTS WITH NEUROENDOCRINE TUMOURS AND CARCINOID HEART DISEASE IN A CONTEMPORARY CANADIAN COHORT

P038 - CLINICAL PREDICTORS AND HEALTHCARE UTILIZATION AMONG CARDIAC AMYLOIDOSIS PATIENTS IN BRITISH COLUMBIA

P039 - ENDOTHELIAL CELL-SPECIFIC LOSS OF BREAST CANCER SUSCEPTIBILITY GENE 2 EXACERBATES ANGIOTENSIN II-INDUCED ENDOTHELIAL DYSFUNCTION

P040 - INVESTIGATING CARDIOTOXICITY OF AROMATASE INHIBITORS: A CASE OF LETROZOLE-INDUCED CARDIOMYOPATHY

P041 - INVESTIGATING HOW THE TUMOUR MICROENVIRONMENT PREDISPOSES THE CARDIOVASCULAR SYSTEM TO CANCER-THERAPY INDUCED CARDIOTOXICITY

P042 - IS EMPAGLIFLOZIN EQUIVALENT AND/OR SYNERGISTIC WITH ACE INHIBITION IN THE TREATMENT OF CHEMOTHERAPY MEDIATED CARDIOTOXICITY?